Verse Medical
AI-enabled durable-medical-equipment ordering and fulfilment platform.
The Company
Verse Medical provides AI-enabled ordering and fulfilment for durable medical equipment, including medical-record validation of necessity and coverage validation. The company is designed to fit into clinical workflows while helping patients receive equipment on time.
Verse says it works with nine of the ten largest health systems by revenue and can fulfil orders across DME categories. Forge reports a $53 million June 2025 Series C at a $735.18 million post-money valuation; those financing figures are database-reported rather than announced by Verse.
Why It Matters
Verse targets a large but operationally difficult healthcare workflow where automation can improve both patient experience and payment integrity. Its opportunity depends on clinical integration, reimbursement compliance and fulfilment execution.
Valuation History
- $735.18M→Jun 2025Reported Series C, $53MSource ↗
What Changed
Private-market databases reported a $53M Series C in June 2025; Verse has not publicly confirmed the valuation.
THE NEXT COMPANY. A CLEARER PICTURE.
Get the next breakdown.
Independent company research and perspectives on private markets, delivered through The Private Ledger on Substack.